INSMED Inc (INSM) stock
INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$121.86−1.02 (-0.83%)
Close on Nov 17, 2026Market cap $26.73BP/E –Yield –
Insmed pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Insmed's pe ratio was 0.6× on Jan 31, 2011.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2011 | Jan 31, 2011 | 0.6× | −0.0 |
| 2010 | Dec 31, 2010 | 0.7× | – |
See a number that looks wrong?